4D Molecular Therapeutics, Inc. (FDMT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
4D Molecular Therapeutics Inc FDMT
$9.91
β² +10.48%
(+$0.94)
Open
$8.90
Prev Close
$8.97
Day Range
$8.90 β $10.00
52W Range
$3.40 β $12.34
Market Cap
$468.92M
Beta
2.75
EPS (TTM)
$-2.70
π Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-12-11 |
| Shares Out. | 52,280,000 |
| Website | 4dmoleculartherapeutics.com/ β |
| Phone | 15105052680 |
4D Molecular Therapeutics Inc is a publicly traded company under the ticker symbol FDMT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
17 analysts (2026-05-01)
